Literature DB >> 9522518

[Pseudomonas aeruginosa bacteremia as a complication after endoscopic retrograde cholangiopancreatography].

A Rodríguez Guardado1, J A Maradona, J A Cartón, N Hooker, J L Alonso, V Asensi, J M Arribas.   

Abstract

BACKGROUND: The present was performed to describe the characteristics of bacteremias by Pseudomonas aeruginosa following cholangiopancreatography and the methods of prevention and treatment of the same.
METHODS: Twelve different episodes of bacteremia by Pseudomonas aeruginosa were retrospectively studied in patients submitted to endoscopic cholangiopancreatography (ERCP) from 1993-1997.
RESULTS: Three point six percent of the patients undergoing ERCP presented episodes of bacteremias by the microorganism in the 48 hours following the procedure. Except for one case, the patients presented obstructive disease in the form of calculi or neoplasms at the level of the biliary tree. In three cases, sphincterotomy had been carried out which was followed by clinical manifestations of hemorrhage in one case. Three patients (25%) died as a consequence of bacteremia and a hepatic abscess was developed in one case. The bacteremia appeared in successive outbreaks from 1993-1997.
CONCLUSIONS: Bacteremia by Pseudomonas aeruginosa following ERCP is more frequent in patients with obstructive disease of the biliary tract and has an important additional morbimortality. It is associated with incorrect endoscopic disinfection. The use of drugs with an antipseudomonal spectrum should be considered as preendoscopic prophylaxis.

Entities:  

Mesh:

Year:  1997        PMID: 9522518

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  1 in total

1.  Endowashers: an overlooked risk for possible post-endoscopic infections.

Authors:  Nils-Olaf Hübner; Ojan Assadian; Rosmarie Poldrack; Oliver Duty; Heinrich Schwarzer; Hiltraud Möller; Paul Kober; Malte Räther; Lutz Werner Schröder; Jeanette Sinha; Markus M Lerch; Axel Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.